"Aspirin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
Descriptor ID |
D001241
|
MeSH Number(s) |
D02.455.426.559.389.657.410.595.176
|
Concept/Terms |
Aspirin- Aspirin
- Acetylsalicylic Acid
- Acid, Acetylsalicylic
- 2-(Acetyloxy)benzoic Acid
|
Below are MeSH descriptors whose meaning is more general than "Aspirin".
Below are MeSH descriptors whose meaning is more specific than "Aspirin".
This graph shows the total number of publications written about "Aspirin" by people in this website by year, and whether "Aspirin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
1998 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2003 | 1 | 1 | 2 |
2005 | 2 | 1 | 3 |
2006 | 1 | 1 | 2 |
2007 | 3 | 1 | 4 |
2008 | 3 | 2 | 5 |
2009 | 3 | 2 | 5 |
2010 | 1 | 0 | 1 |
2011 | 0 | 3 | 3 |
2012 | 1 | 2 | 3 |
2013 | 2 | 4 | 6 |
2014 | 2 | 1 | 3 |
2015 | 1 | 3 | 4 |
2016 | 5 | 3 | 8 |
2017 | 87 | 43 | 130 |
2018 | 68 | 45 | 113 |
2019 | 29 | 27 | 56 |
2020 | 7 | 6 | 13 |
2021 | 10 | 8 | 18 |
To return to the timeline, click here.
Below are the most recent publications written about "Aspirin" by people in Profiles.
-
Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review. Rheumatology (Oxford). 2021 10 02; 60(10):4530-4537.
-
Is Aspirin the True Protective Therapy in Coronavirus Disease 2019 Patients? Anesth Analg. 2021 09 01; 133(3):e41.
-
Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovasc Disord. 2021 08 04; 21(1):375.
-
Aspirin Use, Mechanical Ventilation, and Inhospital Mortality in Coronavirus Disease 2019: Are We Missing Something? Anesth Analg. 2021 08 01; 133(2):e31-e33.
-
Acetylsalicylic Acid Compared with Enoxaparin for the Prevention of Thrombosis and Mechanical Ventilation in COVID-19 Patients: A Retrospective Cohort Study. Clin Drug Investig. 2021 Aug; 41(8):723-732.
-
Effect of aspirin on coronavirus disease 2019: A nationwide case-control study in South Korea. Medicine (Baltimore). 2021 Jul 30; 100(30):e26670.
-
A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial. Trials. 2021 Jul 15; 22(1):451.
-
Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients. Signal Transduct Target Ther. 2021 07 14; 6(1):267.
-
Low-dose aspirin for early COVID-19: does the early bird catch the worm? Expert Opin Investig Drugs. 2021 Aug; 30(8):785-788.
-
Our Aspirin Rose. Thorac Cardiovasc Surg. 2021 06; 69(4):293.